Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (81-90 of 443) with videos related to

Pageof 45
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|March 17, 2006
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depressionKaren Dineen Wagner, Jeffrey Jonas, Robert L Findling, et al.
Journal of Child and Adolescent Psychopharmacology|October 23, 2012
Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trialRobert L Findling, Kathleen McKenna, Willie R Earley, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 13, 2004
A prospective study of stimulant response in preschool children: insights from ROC analysesElizabeth J Short, Michael J Manos, Robert L Findling, et al.
Journal of Child and Adolescent Psychopharmacology|January 9, 2016
Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and CorrelatesAndrew J Freeman, Eric A Youngstrom, Jennifer K Youngstrom, et al.
Clinical Therapeutics|June 20, 2007
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyJoseph Biederman, Suma Krishnan, Yuxin Zhang, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 2002
Discriminative validity of a parent version of the Young Mania Rating ScaleBarbara L Gracious, Eric A Youngstrom, Robert L Findling, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|July 20, 2005
Toward an evidence-based assessment of pediatric bipolar disorderEric A Youngstrom, Robert L Findling, Jen Kogos Youngstrom, et al.
Journal of Child and Adolescent Psychopharmacology|September 13, 2013
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation studyRobert L Findling, Sanjeev Pathak, Willie R Earley, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 4, 2017
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum DisorderPaul Gringras, Tali Nir, John Breddy, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Sex differences in pediatric bipolar disorderJeanne M Duax, Eric A Youngstrom, Joseph R Calabrese, et al.
Pageof 45

Showing results (81-90 of 443) with videos related to

Sort By:
Pageof 45
Journal of the American Academy of Child and Adolescent Psychiatry|March 17, 2006
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depressionKaren Dineen Wagner, Jeffrey Jonas, Robert L Findling, et al.
Journal of Child and Adolescent Psychopharmacology|October 23, 2012
Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trialRobert L Findling, Kathleen McKenna, Willie R Earley, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 13, 2004
A prospective study of stimulant response in preschool children: insights from ROC analysesElizabeth J Short, Michael J Manos, Robert L Findling, et al.
Journal of Child and Adolescent Psychopharmacology|January 9, 2016
Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and CorrelatesAndrew J Freeman, Eric A Youngstrom, Jennifer K Youngstrom, et al.
Clinical Therapeutics|June 20, 2007
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyJoseph Biederman, Suma Krishnan, Yuxin Zhang, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 2002
Discriminative validity of a parent version of the Young Mania Rating ScaleBarbara L Gracious, Eric A Youngstrom, Robert L Findling, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|July 20, 2005
Toward an evidence-based assessment of pediatric bipolar disorderEric A Youngstrom, Robert L Findling, Jen Kogos Youngstrom, et al.
Journal of Child and Adolescent Psychopharmacology|September 13, 2013
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation studyRobert L Findling, Sanjeev Pathak, Willie R Earley, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 4, 2017
Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum DisorderPaul Gringras, Tali Nir, John Breddy, et al.
The Journal of Clinical Psychiatry|October 27, 2007
Sex differences in pediatric bipolar disorderJeanne M Duax, Eric A Youngstrom, Joseph R Calabrese, et al.
Pageof 45